Fundraising Fox
🦊/Companies
Sign in

sphingotec GmbH

Hennigsdorf, DE · Founded 2002 · 20 employees on LinkedIn · 1 known investors

Find your way into sphingotec GmbH

SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Founders & leadership

DBDeborah Bergmann
Deborah BergmanninChief Executive Officer

Investors · 1

Brandenburg KapitalPotsdam · $108K – $5.4M

In the news

sphingotec raises €20 million from HBM and Wellington Partnersprnewswire.com · Oct 2018sphingotec Raises €20M in Equity Financing - FinSMEsfinsmes.com · Oct 2018

Frequently asked questions

What does sphingotec GmbH do?
SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.
Who are sphingotec GmbH's investors?
sphingotec GmbH's investors include Brandenburg Kapital.
Where is sphingotec GmbH headquartered?
sphingotec GmbH is headquartered in Hennigsdorf, DE.